493 related articles for article (PubMed ID: 6202102)
21. [Characterization of hemolytic activity of Proteus penneri].
Rózalski A; Bartodziejska B; Wykrota M; Serwecińska L; Lukomski S; Kotełko K
Med Dosw Mikrobiol; 1993; 45(1):79-83. PubMed ID: 8231450
[TBL] [Abstract][Full Text] [Related]
22. Classification of Proteus mirabilis TG 115 and CCUG 10701 into the Proteus O23 serogroup based on chemical and serological studies of O-polysaccharides.
Zabłotni A; Perepelov AV; Kołodziejska K; Zych K; Knirel YA; Sidorczyk Z
Arch Immunol Ther Exp (Warsz); 2006; 54(6):411-7. PubMed ID: 17122881
[TBL] [Abstract][Full Text] [Related]
23. [Resistance to antibiotics of Proteus strains from various sources].
Korneva EP; Baĭramova AS; Iakh'eva SA; Slutskiĭ VI; Danevich MV
Antibiotiki; 1984 Apr; 29(4):263-71. PubMed ID: 6378079
[TBL] [Abstract][Full Text] [Related]
24. Adhesion of Proteus mirabilis and Proteus vulgaris to uroepithelial cells following exposure to various antimicrobial agents.
Tullio V; Carlone NA; Cuffini AM; Fazari S
Microbios; 1992; 69(278):67-75. PubMed ID: 1588844
[TBL] [Abstract][Full Text] [Related]
25. Proticine typing of serologically defined Proteus strains.
Csiszár K; Lányi B
Acta Microbiol Acad Sci Hung; 1981; 28(1):111-8. PubMed ID: 7020353
[TBL] [Abstract][Full Text] [Related]
26. Proteus virulence: involvement of the pore forming alpha-hemolysin (a short review).
Tóth V; Emódy L
Acta Microbiol Immunol Hung; 2000; 47(4):457-70. PubMed ID: 11056765
[TBL] [Abstract][Full Text] [Related]
27. Serotyping of clinical isolates belonging to Proteus mirabilis serogroup O36 and structural elucidation of the O36-antigen polysaccharide.
Arabski M; Grabowski S; Konieczna I; Kaca W; Kondakova AN; Perepelov AV; Senchenkova SN; Shashkov AS; Knirel YA
FEMS Immunol Med Microbiol; 2008 Aug; 53(3):395-403. PubMed ID: 18625011
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells.
Mobley HL; Chippendale GR; Swihart KG; Welch RA
Infect Immun; 1991 Jun; 59(6):2036-42. PubMed ID: 2037363
[TBL] [Abstract][Full Text] [Related]
29. Structure and serological properties of the O-antigen of two clinical Proteus mirabilis strains classified into a new Proteus O77 serogroup.
Drzewiecka D; Arbatsky NP; Shashkov AS; Staczek P; Knirel YA; Sidorczyk Z
FEMS Immunol Med Microbiol; 2008 Nov; 54(2):185-94. PubMed ID: 18665848
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of haemolytic activity in Proteus strains.
Kandela SA; al-Shibib AS
Acta Microbiol Pol; 1990; 39(3-4):149-55. PubMed ID: 1715649
[TBL] [Abstract][Full Text] [Related]
31. Proteus morgani is less frequently associated with urinary tract infections than Proteus mirabilis--an explanation.
Senior BW
J Med Microbiol; 1983 Aug; 16(3):317-22. PubMed ID: 6348289
[TBL] [Abstract][Full Text] [Related]
32. Quantification of Proteus mirabilis virulence factors and modulation by acylated homoserine lactones.
Stankowska D; Kwinkowski M; Kaca W
J Microbiol Immunol Infect; 2008 Jun; 41(3):243-53. PubMed ID: 18629420
[TBL] [Abstract][Full Text] [Related]
33. Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model.
Fraga M; Scavone P; Zunino P
Antonie Van Leeuwenhoek; 2005 Jul; 88(1):25-34. PubMed ID: 15928974
[TBL] [Abstract][Full Text] [Related]
34. Lecithinase activity of Proteus vulgaris.
Postupa R; Postupová M
J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):227-31. PubMed ID: 3045200
[TBL] [Abstract][Full Text] [Related]
35. Different binding specificities of P. mirabilis compared to E. coli.
Lomberg H; Larsson P; Leffler H; Svanborg-Edén C
Scand J Infect Dis Suppl; 1982; 33():37-42. PubMed ID: 6753134
[TBL] [Abstract][Full Text] [Related]
36. Outer membrane protein profiles and multilocus enzyme electrophoresis analysis for differentiation of clinical isolates of Proteus mirabilis and Proteus vulgaris.
Kappos T; John MA; Hussain Z; Valvano MA
J Clin Microbiol; 1992 Oct; 30(10):2632-7. PubMed ID: 1400963
[TBL] [Abstract][Full Text] [Related]
37. alpha-Haemolysin: an additive virulence factor in Escherichia coli.
Emödy L; Pál T; Safonova NV; Kuch B; Golutva NK
Acta Microbiol Acad Sci Hung; 1980; 27(4):333-42. PubMed ID: 7008511
[TBL] [Abstract][Full Text] [Related]
38. [Bacteriocinogenic properties of Proteus].
Shvidenko IG
Zh Mikrobiol Epidemiol Immunobiol; 1978 Jan; (1):27-30. PubMed ID: 343455
[TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of a haemolysin from Trichophyton mentagrophytes.
Schaufuss P; Müller F; Valentin-Weigand P
Vet Microbiol; 2007 Jun; 122(3-4):342-9. PubMed ID: 17336469
[TBL] [Abstract][Full Text] [Related]
40. [Determination of bacteriocinogenic types of strains of Proteus mirabilis].
Józefowicz-Piatkowska H; Piatkowski K
Med Dosw Mikrobiol; 1994; 46(3):151-60. PubMed ID: 7996932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
